New England Biolabs® Launches NEBNext® Enzymatic 5hmC-seq Kit, for enzyme-based 5hmC detection at single-base resolution
IPSWICH, Mass., Feb. 13, 2024 /PRNewswire/ -- New England Biolabs (NEB®) today announced the launch of the NEBNext Enzymatic 5hmC-seq Kit (E5hmC-seq™), a novel enzyme-based method for the specific detection of 5hmC sites. The gentle, enzyme-based approach enables high yields and high-quality data, with an input range of 100 pg to 200 ng.
- IPSWICH, Mass., Feb. 13, 2024 /PRNewswire/ -- New England Biolabs (NEB®) today announced the launch of the NEBNext Enzymatic 5hmC-seq Kit (E5hmC-seq™), a novel enzyme-based method for the specific detection of 5hmC sites.
- "While NEBNext Enzymatic Methyl-seq (EM-seq™), our gold standard for methylation detection, detects both 5mC and 5hmC, it does not distinguish between them.
- "To address these challenges, we developed the NEBNext Enzymatic 5hmC-seq Kit, which allows for the specific detection of 5hmC sites using a two-step enzymatic conversion workflow," said Stewart.
- "The enzymatic method minimizes DNA damage and allows for the discrimination of 5hmC from unmodified cytosine and 5mC after Illumina® sequencing.